SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers rebound to a fresh 52-week high and push through a key round-number level are driving attention, with traders cheering the momentum while others question whether the breakout can hold without a stronger catalyst. Earnings and pipeline progress are also in view, alongside the stocks appeal as a dividend-paying defensive holding.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Anticipation of Lillys quarterly results and analyst expectations for continued growth in its obesity-drug business are driving discussion. Traders are debating whether Foundayo and the broader GLP-1 pipeline can sustain Lillys lead against Novo and other competitors, with optimism about demand balanced by concerns over valuation and competition.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras investigational treatment for menopausal hot flashes: traders are weighing its positive Phase 2 results and additional clinical data presented at a menopause conference. The reaction is broadly bullish, reinforced by new analyst coverage, but some say the news may already be priced in and emphasize that further trials are needed to confirm the findings.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus shares are drawing attention for their steep selloff and fresh lows, with traders frequently blaming share dilution and questioning the valuation and funding needs of its capital-intensive enrichment expansion. Some see the decline as an opportunity based on long-term U.S. nuclear-fuel demand, while others remain concerned about further downside and execution risks.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies expanded stock buyback program, raised to $100 million and extended into 2027, is drawing attention. Some traders see the repurchases as support for PURR, while others question their effect as the company focuses on accumulating HYPE and the token remains weak.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Brazils presidential runoff is the main focus, with traders positioning for a possible Petrobras rally if Flvio Bolsonaro wins and expecting a more shareholder-friendly policy direction; talk of partial privatization remains hypothetical. The bullish election trade is accompanied by caution about a potential sell-the-news reaction and uncertainty over the outcome.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

Renewed selling in Chinese internet stocks has erased a short-lived China-tech rally, leaving KWEB near multi-year lows. Traders are divided between buying the oversold pullback and expecting a rebound, and arguing that weak demand, limited market support and persistent policy and geopolitical risks keep the sector under pressure.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens IMDELLTRAIMFINZI combination drew attention after Phase 3 results showed a substantial survival benefit in first-line extensive-stage small-cell lung cancer. Traders see the data as a potential growth driver and a boost to Amgens oncology pipeline, while debating how much it could add to the business.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is drawing attention as crude prices climb on Middle East shipping and supply-disruption fears, with traders debating whether the rally has further room or is due for a pullback. The discussion also touches on the proposed Russian diesel supply as a potential counterweight to tight fuel markets.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems encouraging early VS-7375 data in KRAS G12D cancers, including pancreatic cancer, and plans for a Phase 3 study are driving attention. Traders are broadly positive about the drugs potential but debate the small early-stage cohorts, competition, and dilution from the financing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenia Hotels & Resorts Declares Dividend for Third Quarter 2026

Xenia Hotels & Resorts Declares Dividend for Third Quarter 2026 Xenia Hotels & Resorts Declares Dividend for Third Quarter 2026PR NewswireORLANDO, Fla., Sept. 21, 2026 ORLANDO, Fla., Sept. 21, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE: XHR) ("Xenia" or the "Company") today announced...

Xenia Hotels & Resorts Announces Timing of Third Quarter 2026 Earnings Release and Conference Call

Xenia Hotels & Resorts Announces Timing of Third Quarter 2026 Earnings Release and Conference Call Xenia Hotels & Resorts Announces Timing of Third Quarter 2026 Earnings Release and Conference Call PR Newswire ORLANDO, Fla., Sept. 10, 2026 ORLANDO, Fla., Sept. 10, 2026 /PRNewswire/ -- Xenia Hotels...

Xenia Hotels & Resorts Reports Second Quarter 2026 Results

Xenia Hotels & Resorts Reports Second Quarter 2026 Results Xenia Hotels & Resorts Reports Second Quarter 2026 Results PR Newswire Orlando, Fla., July 30, 2026 Orlando, Fla., July 30, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE: XHR) ("Xenia" or the "Company") today announced results for...

Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call

Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call Xenia Hotels & Resorts Announces Timing of Second Quarter 2026 Earnings Release and Conference Call PR Newswire ORLANDO, Fla., June 18, 2026 ORLANDO, Fla., June 18, 2026 /PRNewswire/ -- Xenia Hotels...

Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026

Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026 Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026 PR Newswire ORLANDO, Fla., May 15, 2026 ORLANDO, Fla., May 15, 2026...

XHR Crosses Above Average Analyst Target

In recent trading, shares of Xenia Hotels & Resorts Inc (Symbol: XHR) have crossed above the average analyst 12-month target price of $16.40, changing hands for $16.71/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow...

Xenia Hotels & Resorts Q1 Earnings Call Highlights

Xenia Hotels & Resorts (NYSE:XHR) reported first-quarter 2026 results that management said exceeded expectations across key metrics, driven by strength in both group and transient demand particularly...

Xenia Hotels & Resorts (NYSE:XHR) Releases Earnings Results, Beats Estimates By $0.45 EPS

Xenia Hotels & Resorts (NYSE:XHR - Get Free Report) announced its earnings results on Friday. The real estate investment trust reported $0.63 EPS for the quarter, topping the consensus estimate of $0.18 by $0.45. Xenia Hotels & Resorts had a return on equity of 5.13% and a net margin of 5.85%.The...

Transcript: Xenia Hotels & Resorts Q1 2026 Earnings Conference Call

Xenia Hotels & Resorts (NYSE:XHR) Sets New 52-Week High After Better-Than-Expected Earnings

Xenia Hotels & Resorts (NYSE:XHR) Hits New 12-Month High After Earnings Beat...

Xenia Hotels & Resorts, Inc. is a real estate investment trust, which engages in the provision of investment in luxury and upper upscale hotels and resorts. It also owns a diversified portfolio of lodging properties operated by Marriott, Kimpton, Hyatt, Aston, Fairmong, and Loews. The company was founded in 2007 and is headquartered in Orlando, FL.

Xenia Hotels & Resorts Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$19.51
Prev Close	$19.50
Open	$19.37
Dividend Yield	3.96%
50-Day Moving Average	$18.48
Beta	1.12
Avg. Volume	917,456.89
PE Ratio	-241.16

52-Week High	$22.06
52-Week Low	$11.75
Market Capitalization	$1.8B
EPS (Annual)	$0.6442
Price to Book	1.62
Revenue Per Employee	$25.68M

Feed

News

Sentiment

Earnings

Fundamentals

Info

XHR Fundamentals